Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Adult |
Dose: Tablet or Injection – 200 mg Frequency: once daily Duration: 6 days Note: by mouth or intravenous. Hepatic impairment: No dosage adjustment required |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: less than 18 years |
Dose: Not established Note: Safety and efficacy not established |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment or hemodialysis |
Dose: Not specified Note: No dosage adjustment required |
Administration
- Can be taken with or without food
- For IV: Infuse over 1 hour
Side Effect
- Nausea (8%)
- Headache (6%)
- Diarrhea (4%)
- Hemoglobin Less than 10.1 g/dL (3.1%)
- Vomiting (3%)
- Platelets Less than 112 x 10³/mm³ (2.3%)
- Dizziness (2%)
- Blood and lymphatic system disorders Anemia
- Cardiovascular Palpitations
- tachycardia
- Eye disorders Asthenopia
- vision blurred
- visual impairment
- vitreous floaters
- General disorders and administration site conditions Infusion-related reactions
- Immune system disorders Drug hypersensitivity
- Infections and infestations Clostridium difficile colitis
- oral candidiasis
- vulvovaginal mycotic infection
- Investigations Hepatic transaminases increased
- decreased WBCs
- Nervous system disorders Hypoesthesia
- paresthesia
- seventh nerve paralysis
- Psychiatric disorders Insomnia
- Skin and subcutaneous tissue disorders Pruritus
- urticaria
- dermatitis
- Vascular disorders Flushing
- hypertension
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Rosuvastatin
|
Increased AUC & Cmax
|
|
BCRP Substrates (Breast Cancer Resistance Protein substrates)
|
May increase plasma concentration and potential for adverse reactions
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general drug reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Tablets and injection should be stored at 20°C to 25°C
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.